Management of the Spectrum of Hormone Refractory Prostate Cancer
- 30 September 2006
- journal article
- review article
- Published by Elsevier in European Urology
- Vol. 50 (3) , 428-439
- https://doi.org/10.1016/j.eururo.2006.05.017
Abstract
No abstract availableKeywords
This publication has 89 references indexed in Scilit:
- Phase II study of oral capecitabine in patients with hormone-refractory prostate cancerProstate Cancer and Prostatic Diseases, 2005
- Chemotherapy in Hormone Refractory Prostate Cancer: Where Do We Stand?European Urology, 2004
- Randomized, Double-Blind, Controlled Trial of Mitoxantrone/Prednisone and Clodronate Versus Mitoxantrone/Prednisone and Placebo in Patients With Hormone-Refractory Prostate Cancer and PainJournal of Clinical Oncology, 2003
- Metastatic bone disease and the role of biochemical markers of bone metabolism in benign and malignant diseasesCancer Treatment Reviews, 2001
- The effect of a single fraction compared to multiple fractions on painful bone metastases: a global analysis of the Dutch Bone Metastasis StudyRadiotherapy and Oncology, 1999
- Spinal cord compression in prostate cancerJournal of Neuro-Oncology, 1995
- Hormonal Treatment of Obstructed Kidneys in Patients with Prostatic CancerBritish Journal of Urology, 1993
- Lymphedema following the surgical treatment of breast cancer: A review of pathophysiology and treatmentJournal of Pain and Symptom Management, 1992
- A prospective, randomised double-blind crossover study to examine the efficacy of strontium-89 in pain palliation in patients with advanced prostate cancer metastatic to boneEuropean Journal of Cancer and Clinical Oncology, 1991
- ANEMIA OF CANCERAnnals of the New York Academy of Sciences, 1974